3.26.1 html 218 219 1 false 44 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://healthproductscorp.us/20260331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://healthproductscorp.us/20260331/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://healthproductscorp.us/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited- Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://healthproductscorp.us/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Financial Statements of Stockholders' Equity (Unaudited) Sheet http://healthproductscorp.us/20260331/role/statement-condensed-consolidated-financial-statements-of-stockholders-equity-unaudited- Condensed Consolidated Financial Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://healthproductscorp.us/20260331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited- Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements Sheet http://healthproductscorp.us/20260331/role/statement-note-1-nature-of-operations-principles-of-consolidation-and-basis-of-presentation-of-interim-financial-statements Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Inventories Sheet http://healthproductscorp.us/20260331/role/statement-note-2-inventories Note 2 - Inventories Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Property and Equipment, Net Sheet http://healthproductscorp.us/20260331/role/statement-note-3-property-and-equipment-net Note 3 - Property and Equipment, Net Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Lines of Credit Sheet http://healthproductscorp.us/20260331/role/statement-note-4-lines-of-credit Note 4 - Lines of Credit Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Significant Risks and Uncertainties Sheet http://healthproductscorp.us/20260331/role/statement-note-5-significant-risks-and-uncertainties Note 5 - Significant Risks and Uncertainties Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies Sheet http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies Note 6 - Leases and Other Commitments and Contingencies Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Related Party Transactions Sheet http://healthproductscorp.us/20260331/role/statement-note-7-related-party-transactions Note 7 - Related Party Transactions Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Equity Transactions and Stock-based Compensation Sheet http://healthproductscorp.us/20260331/role/statement-note-8-equity-transactions-and-stockbased-compensation Note 8 - Equity Transactions and Stock-based Compensation Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Segment Information and Disaggregated Revenue Sheet http://healthproductscorp.us/20260331/role/statement-note-9-segment-information-and-disaggregated-revenue Note 9 - Segment Information and Disaggregated Revenue Notes 15 false false R16.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 16 false false R17.htm 995461 - Disclosure - Significant Accounting Policies (Policies) Sheet http://healthproductscorp.us/20260331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies 17 false false R18.htm 995462 - Disclosure - Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements (Tables) Sheet http://healthproductscorp.us/20260331/role/statement-note-1-nature-of-operations-principles-of-consolidation-and-basis-of-presentation-of-interim-financial-statements-tables Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements (Tables) Tables http://healthproductscorp.us/20260331/role/statement-note-1-nature-of-operations-principles-of-consolidation-and-basis-of-presentation-of-interim-financial-statements 18 false false R19.htm 995463 - Disclosure - Note 2 - Inventories (Tables) Sheet http://healthproductscorp.us/20260331/role/statement-note-2-inventories-tables Note 2 - Inventories (Tables) Tables http://healthproductscorp.us/20260331/role/statement-note-2-inventories 19 false false R20.htm 995464 - Disclosure - Note 3 - Property and Equipment, Net (Tables) Sheet http://healthproductscorp.us/20260331/role/statement-note-3-property-and-equipment-net-tables Note 3 - Property and Equipment, Net (Tables) Tables http://healthproductscorp.us/20260331/role/statement-note-3-property-and-equipment-net 20 false false R21.htm 995465 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies (Tables) Sheet http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies-tables Note 6 - Leases and Other Commitments and Contingencies (Tables) Tables http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies 21 false false R22.htm 995466 - Disclosure - Note 8 - Equity Transactions and Stock-based Compensation (Tables) Sheet http://healthproductscorp.us/20260331/role/statement-note-8-equity-transactions-and-stockbased-compensation-tables Note 8 - Equity Transactions and Stock-based Compensation (Tables) Tables http://healthproductscorp.us/20260331/role/statement-note-8-equity-transactions-and-stockbased-compensation 22 false false R23.htm 995467 - Disclosure - Note 9 - Segment Information and Disaggregated Revenue (Tables) Sheet http://healthproductscorp.us/20260331/role/statement-note-9-segment-information-and-disaggregated-revenue-tables Note 9 - Segment Information and Disaggregated Revenue (Tables) Tables http://healthproductscorp.us/20260331/role/statement-note-9-segment-information-and-disaggregated-revenue 23 false false R24.htm 995468 - Disclosure - Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements (Details Textual) Sheet http://healthproductscorp.us/20260331/role/statement-note-1-nature-of-operations-principles-of-consolidation-and-basis-of-presentation-of-interim-financial-statements-details-textual Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements (Details Textual) Details http://healthproductscorp.us/20260331/role/statement-note-1-nature-of-operations-principles-of-consolidation-and-basis-of-presentation-of-interim-financial-statements-tables 24 false false R25.htm 995469 - Disclosure - Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements - Dilutive Shares For Stock Options (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-1-nature-of-operations-principles-of-consolidation-and-basis-of-presentation-of-interim-financial-statements-dilutive-shares-for-stock-options-details Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements - Dilutive Shares For Stock Options (Details) Details 25 false false R26.htm 995470 - Disclosure - Note 2 - Inventories - Inventories (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-2-inventories-inventories-details Note 2 - Inventories - Inventories (Details) Details 26 false false R27.htm 995471 - Disclosure - Note 3 - Property and Equipment, Net (Details Textual) Sheet http://healthproductscorp.us/20260331/role/statement-note-3-property-and-equipment-net-details-textual Note 3 - Property and Equipment, Net (Details Textual) Details http://healthproductscorp.us/20260331/role/statement-note-3-property-and-equipment-net-tables 27 false false R28.htm 995472 - Disclosure - Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-3-property-and-equipment-net-property-and-equipment-net-details Note 3 - Property and Equipment, Net - Property and Equipment, Net (Details) Details 28 false false R29.htm 995473 - Disclosure - Note 4 - Lines of Credit (Details Textual) Sheet http://healthproductscorp.us/20260331/role/statement-note-4-lines-of-credit-details-textual Note 4 - Lines of Credit (Details Textual) Details http://healthproductscorp.us/20260331/role/statement-note-4-lines-of-credit 29 false false R30.htm 995474 - Disclosure - Note 5 - Significant Risks and Uncertainties (Details Textual) Sheet http://healthproductscorp.us/20260331/role/statement-note-5-significant-risks-and-uncertainties-details-textual Note 5 - Significant Risks and Uncertainties (Details Textual) Details http://healthproductscorp.us/20260331/role/statement-note-5-significant-risks-and-uncertainties 30 false false R31.htm 995475 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies (Details Textual) Sheet http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies-details-textual Note 6 - Leases and Other Commitments and Contingencies (Details Textual) Details http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies-tables 31 false false R32.htm 995476 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Lease Expense (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies-lease-expense-details Note 6 - Leases and Other Commitments and Contingencies - Lease Expense (Details) Details 32 false false R33.htm 995477 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Leases and Commitments (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies-leases-and-commitments-details Note 6 - Leases and Other Commitments and Contingencies - Leases and Commitments (Details) Details 33 false false R34.htm 995478 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Supplemental Cash Flow Information (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies-supplemental-cash-flow-information-details Note 6 - Leases and Other Commitments and Contingencies - Supplemental Cash Flow Information (Details) Details 34 false false R35.htm 995479 - Disclosure - Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-6-leases-and-other-commitments-and-contingencies-minimum-rental-commitment-for-longterm-noncancelable-leases-details Note 6 - Leases and Other Commitments and Contingencies - Minimum Rental Commitment for Long-term Non-cancelable Leases (Details) Details 35 false false R36.htm 995480 - Disclosure - Note 8 - Equity Transactions and Stock-based Compensation (Details Textual) Sheet http://healthproductscorp.us/20260331/role/statement-note-8-equity-transactions-and-stockbased-compensation-details-textual Note 8 - Equity Transactions and Stock-based Compensation (Details Textual) Details http://healthproductscorp.us/20260331/role/statement-note-8-equity-transactions-and-stockbased-compensation-tables 36 false false R37.htm 995481 - Disclosure - Note 8 - Equity Transactions and Stock-based Compensation - Fair Value of Stock Option Using Black-Scholes Option Pricing Model (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-8-equity-transactions-and-stockbased-compensation-fair-value-of-stock-option-using-blackscholes-option-pricing-model-details Note 8 - Equity Transactions and Stock-based Compensation - Fair Value of Stock Option Using Black-Scholes Option Pricing Model (Details) Details 37 false false R38.htm 995482 - Disclosure - Note 8 - Equity Transactions and Stock-based Compensation - Summary of the Company's Stock Option Activity, and Related Information (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-8-equity-transactions-and-stockbased-compensation-summary-of-the-companys-stock-option-activity-and-related-information-details Note 8 - Equity Transactions and Stock-based Compensation - Summary of the Company's Stock Option Activity, and Related Information (Details) Details 38 false false R39.htm 995483 - Disclosure - Note 9 - Segment Information and Disaggregated Revenue (Details Textual) Sheet http://healthproductscorp.us/20260331/role/statement-note-9-segment-information-and-disaggregated-revenue-details-textual Note 9 - Segment Information and Disaggregated Revenue (Details Textual) Details http://healthproductscorp.us/20260331/role/statement-note-9-segment-information-and-disaggregated-revenue-tables 39 false false R40.htm 995484 - Disclosure - Note 9 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) Sheet http://healthproductscorp.us/20260331/role/statement-note-9-segment-information-and-disaggregated-revenue-operations-by-business-segment-details Note 9 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) Details 40 false false All Reports Book All Reports inbp-20260331.xsd inbp-20260331_cal.xml inbp-20260331_def.xml inbp-20260331_lab.xml inbp-20260331_pre.xml inbp20260331_10q.htm http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true